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tion of the lateral association between ab-tubulin molecules in the microtubule wall. Thesemodifications of microtubule structure,
through a not-yet-characterized mechanism, are most likely related to the changes in tubulin-tubulin interactions responsible for
microtubule stabilization by these antitumor compounds. We have used a set of modified taxanes to study the structural mecha-
nism of microtubule stabilization by these ligands. Using small-angle x-ray scattering, we have determined how modifications in
the shape and size of the taxane substituents result in changes in the interprotofilament angles and in their number. The observed
effects have been explained using NMR-aided docking and molecular dynamic simulations of taxane binding at the microtubule
pore and luminal sites. Modeling results indicate that modification of the size of substituents at positions C7 andC10 of the taxane
core influence the conformation of three key elements in microtubule lateral interactions (the M-loop, the S3 b-strand, and the H3
helix) that modulate the contacts between adjacent protofilaments. In addition, modifications of the substituents at position C2
slightly rearrange the ligand in the binding site, modifying the interaction of the C7 substituent with the M-loop.INTRODUCTIONFully assembled microtubules are long hollow cylinders
~25 nm in diameter composed of laterally associated tubulin
protofilaments. The number of protofilaments per microtu-
bule can range from 10 to 18, although the number is usually
13 in vivo (1). In contrast, this number is variable in vitro and
depends on the experimental conditions. It should be stressed
that the actual protofilament number is heterogeneous and
follows a distribution. In fact, the number of protofilaments
is given as an average figure (1).
Taxanes are a class of antitumor drugs in clinical use (2)
that exert their cytotoxic action through the microtubule cy-
toskeleton. Paclitaxel (Fig. 1) and its chemical relatives,
such as docetaxel, belong to this group of drugs (3). Taxanes
prevent microtubule disassembly by activation of GDP-
bound tubulin (4,5). They were the first available class
of compounds with microtubule-stabilizing-agent (MSA)
activity.
Several models have been proposed (see Wu et al. (6)
for a review) to explain the structural mechanisms of micro-
tubule assembly. The most simplistic of these proposes one-
by-one addition of tubulin dimers to the growing end of a
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0006-3495/11/12/2970/11 $2.00induced microtubule assembly has been studied using
small-angle x-ray scattering (SAXS) (8). Under the bio-
chemical conditions of this study, and in the presence of
MSA, the first structural step of the assembly involves
head-to-tail oligomerization of tubulin dimers in the pres-
ence of Mgþ2 ions to form linear oligomers, called protofila-
ments. These linear oligomers laterally associate to form the
nucleus (a process mediated by the MSA), which grows
until the number of protofilaments is sufficient to display
cylindrical morphology, with the correct interprotofilament
angle (Fig. 1). This so-called interprotofilament angle is
defined as the average angle between protofilaments in the
cylindrical cross section (see Fig. 2 A, inset). The nucleus
then elongates by incorporating new tubulin subunits to
the growing end of the cylinder. This model is compatible
with previous observations of intermediate sheet structures
(9) and with the observed fast growth of existing microtu-
bules from elongation of sheetlike structures at the growing
ends (10). However, we should point out that although the
MSA-induced microtubule assembly, employed in this
study, can be considered as a model system of the physio-
logical GTP-induced microtubule assembly, the exact mech-
anism of GTP-induced tubulin assembly both in vivo and
in vitro is controversial (11,12), and microtubule formation
may proceed through a different structural pathway.
In earlier studies on the interaction of taxanes with micro-
tubules, we found that the structure of paclitaxel-induced
microtubules is different from the structure of those assem-
bled in the absence of this drug (13). In the presence ofdoi: 10.1016/j.bpj.2011.11.005
FIGURE 1 (Upper) Structural pathway of MSA-
induced microtubule assembly, adapted from Dı´az
et al. (8). (Lower) Chemical structures of the
compounds employed in this study.
Taxanes Modify Microtubule Structure 2971paclitaxel, microtubules assembled with an average of
12.1 protofilaments (13), which is rather different from the
average number of protofilaments found invitro (13.4). Strik-
ingly, when assembled in the presence of docetaxel, the
microtubules have an average protofilament number identical
to that found in the absence of drugs (14). The most straight-
forward explanation for this observation would be that these
compounds can alter theway inwhich protofilaments interact
laterally. In addition, the exchange of paclitaxel for doce-
taxel, or the addition of Flutax-2 (a chemically modified
fluorescent analog) to microtubules preassembled in the
absence of drugs resulted in rapid changes (within a timescale
of<1min) in the number of protofilaments (8,15,16). There-
fore, the mechanism of MSA-induced assembly should
modify the interprotofilament angle and subsequently the
average number of microtubule protofilaments.
Although high-resolution electron diffraction located the
main paclitaxel binding site on the internal surface of micro-tubules (17), rather remote from the interprotofilament
space, our studies (18–21) have provided evidence that
another binding site exists for MSAs. This site is in the
vicinity of residue T220 of b-tubulin (at the outer surface
of the pore in the microtubule wall). On the other hand, it
has been described that binding of paclitaxel to the luminal
site of microtubules facilitates the interaction between the
S7-H9 loop (M-loop) of b-tubulin and the H1-S2 loop of
the adjacent subunit (17). This enhanced M-loop-H1-S2-
loop interaction has been proposed as one of the key reasons
for the microtubule-stabilizing activity of paclitaxel (22). In
both cases (binding in the outer surface of the pore or
binding at the luminal site), MSA-tubulin interactions take
place close to the interprotofilament region, so it is not
unreasonable to imagine that they should modify the corre-
sponding angle and, thus, the microtubule structure.
Herein, we have employed SAXS to determine the
average microtubule diameter and the number ofBiophysical Journal 101(12) 2970–2980
FIGURE 2 Effect of single modifications in the different side chains on
the SAXS profiles of microtubules assembled in the presence of different
taxanes. (A) Effect of changes in the C13 side chain. SAXS profiles of
microtubules assembled in the presence of Chitax-21 (black line), cephalo-
mannine (red or dark gray line), and paclitaxel (green or light gray line).
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2972 Matesanz et al.protofilaments. By comparing SAXS data of microtubules
assembled in the presence of a series of different modified
taxanes (Fig. 1), it has been possible to shed light on the
mechanisms involved in the modification of the microtubule
structure by these ligands. On this basis, the goal of this
work has been to obtain insights, at molecular and atomic
resolution, into the mechanisms of MSA-induced microtu-
bule assembly by understanding how ligands with different
chemical functional groups may modify the interactions
between protofilaments. These events are probably related
to those that modulate tubulin-tubulin interactions and
induce microtubule assembly. Therefore, taxane derivatives
with different sizes and shapes have been selected from
a library of active compounds (23). In particular, a number
of molecules were selected for our study based on different
observations; since the first differences in the observed
number of protofilaments involved paclitaxel and docetaxel,
which mainly differ in the substitutions at the C13 lateral
chain (in the eastern part of the molecule), these two mole-
cules and related analogs were initially selected for our
study. However, between these two key molecules there is
also one smaller modification at position 10 (in the northern
part of the taxane core), which was also chosen for further
exploration. On the other hand, we also decided to explore
the consequences of the chemical differences between
paclitaxel, Flutax-1, and Flutax-2, which involve the C7
lateral chain (in the northeastern part of the taxane core).
In addition, the effect of modifications at the C2 side chain
(in the southern part) has also been evaluated, since these
modifications have a significant influence on the binding
of taxanes to microtubules (23).MATERIALS AND METHODS
Ligands and protein
Purified calf brain tubulin and chemicals were synthesized and used as
described (5,16,18,23,24). Baccatin III was from Sigma-Aldrich (St. Louis,
MO). All compounds were dissolved at 50 mM concentration in D6-DMSO.X-ray scattering measurements
Tubulin was equilibrated in a buffer of 10 mM sodium phosphate, 1 mM
EDTA, 0.1 mM GTP, pH 7.0, through a Sephadex G-25 medium column
(25  9 mm), and the protein was centrifuged for 20 min at 90,000  g
in a TLA120.2 rotor in an Optima TLX centrifuge (Beckman, Palo Alto,
CA) to remove aggregates. The tubulin concentration was then determined(Inset) Schematic drawing of a microtubule indicating the interprotofila-
ment angle. (B) Effect of changes in the C10 side chain. SAXS profiles
of microtubules assembled in the presence of Chitax-18 (black line), ceph-
alomannine (red or dark gray line), and Chitax-17 (green or light gray line).
(C) Effect of changes in the C7 side chain. SAXS profiles of microtubules
assembled in the presence of Chitax-1 (black line), cephalomannine (red
line), and Chitax-17 (green line). (D) Effect of changes in the C2 side chain.
SAXS profiles of microtubules assembled in the presence of Chitax-13
(black line), cephalomannine (red or dark gray line), and Chitax-14 (green
or light gray line).
Taxanes Modify Microtubule Structure 2973spectrophotometrically as described previously (25). MgCl2 (7 mM) and up
to 1 mM GTP were added to the sample (final pH 6.7), the desired ligand or
DMSO (vehicle) in a 10% stoichiometric excess over the protein concentra-
tion was added, and the samples were incubated for 20 min at 37C and kept
at 25C before recording the scattering patterns.
SAXS data collection was performed either at BM26B station (DUB-
BLE) of the European Synchrotron Radiation Facility in Grenoble (France)
or at a Bruker (Rheinstetten, Germany) NANOSTAR system (see Support-
ing Material for details).
The low-angle x-ray scattering pattern of microtubules in solution can be
described as the Fourier transform of a hollow cylinder. To a first approxi-
mation, the intensity is given by the zeroth-order Bessel function, jJ0ðqRÞj2;
where q is the scattering angle and R the cylinder radius (26). The position
of the first scattering maximum is therefore a sensitive measure for the
radius of the microtubule, via the relation J01¼ (1.22/2R), since in a solution
scattering pattern these are not distorted due to overlap between the higher-
order diffraction maxima of the helical lattice (13,14).
The differences in diameter between microtubules assembled in the pres-
ence of different taxanes can be interpreted, to a good approximation, as
changes in the average number of protofilaments making up the cylinder
wall.TABLE 1 Structural data of the ligand-induced microtubulesNMR sample preparation and experiments
The samples of the ligands bound to microtubules were prepared, measured
at 310 K in D2O on Bruker AVANCE 500 MHz or 700 MHz spectrometers
and analyzed as described previously (21). Off-rate constants in the range
1–200,000 s1 were tested to fit the experimental saturation transfer
difference (STD) effects and transferred nuclear Overhauser enhancement
(TR-NOE) intensities. Optimal agreement was achieved for koff ¼ 90 s1
for cephalomannine, Chitax-1, Chitax-4, and Chitax-17, and koff ¼







Baccatin III 0.05955 0.0006 10.35 0.2 11.35 0.3
Cephalomannine 0.05355 0.0002 11.45 0.1 12.65 0.1
Paclitaxel 0.05185 0.0004 11.85 0.1 13.05 0.1
Docetaxel 0.04805 0.0005 12.75 0.2 14.05 0.2
Chitax-1 0.04555 0.0002 13.45 0.1 14.85 0.1
Chitax-4 0.04435 0.0008 13.85 0.3 15.25 0.3
Chitax-5 0.04355 0.0005 14.05 0.1 15.55 0.1
Chitax-11 0.04985 0.0003 12.25 0.1 13.55 0.1
Chitax-12 0.05015 0.0003 12.25 0.1 13.45 0.1
Chitax-13 0.05185 0.0004 11.85 0.1 13.05 0.1
Chitax-14 0.04935 0.0002 12.45 0.1 13.65 0.1
Chitax-15 0.05045 0.0003 12.15 0.1 13.35 0.1
Chitax-17 0.05015 0.0003 12.25 0.1 13.45 0.1
Chitax-18 0.05435 0.0004 11.25 0.1 12.45 0.1
Chitax-19 0.04765 0.0003 12.85 0.1 14.15 0.1
Chitax-20 0.05035 0.0004 12.15 0.1 13.45 0.1
Chitax-21 0.05135 0.0006 11.95 0.2 13.15 0.3Docking and molecular dynamics calculations
Docking of the ligands was performed as described (21) (see Supporting
Material for details).
Autodock poses with the best fitting between experimental and calcu-
lated STD values were refined by using molecular dynamics (MD) simula-
tions performed with AMBER 9 (27) (500-ps equilibration time, 2-ns
acquisition time). For each compound, 100 structures were saved along
the last nanosecond of the MD trajectory. The predicted STD values of
each structure were obtained with CORCEMA-ST and the average STD
values of these 100 structures were considered for comparison against the
experimental data. Finally, the normalized root mean-square deviation
(NRMSD) between these average STD values and the experimental STD
were calculated for each proton of the ligand.
The volume of the solvent-excluded surface (V-SES) by the side chains
of the taxanes was calculated using the MSMS program (28) to calculate the
excluded surface and the Chimera program (29) to calculate the volume
under the excluded surface.Chitax-40 0.05215 0.0005 11.75 0.2 12.95 0.2
Flutax-1 0.04605 0.0002 13.35 0.1 14.65 0.1
Flutax-2 0.04605 0.0002 13.35 0.1 14.65 0.1
Hexaflutax 0.04465 0.0003 13.75 0.1 15.15 0.1
*Values indicate the position of the J01 maxima in the scattering profiles
obtained from three independent measurements. Fitting of the peaks was
done using the curve-fitting software tool TableCurve2D 5.01 (Systat
Software, Richmond, CA). The error is the error of the best fit.
yValues are the helical radii estimated from the positions of the first subsid-
iary maxima of the J0 Bessel function J01 ¼ 1.22/2R (26).
zCalculated from the mean helical radius and the microtubule interprotofila-
ment spacing (5.7 nm) (14).RESULTS
SAXS determination of the sizes
of the ligand-induced microtubules
Tubulin assembly was induced in the presence of the dif-
ferent ligands, and the corresponding SAXS profiles were
recorded for each microtubule population. Fig. 2 shows a
comparison of the profiles for selected molecules that differ
in a single position of the taxane side chain. From theseprofiles, the positions of the first-order Bessel function
maxima J01 were determined, and appropriate controls
were performed to assure that the position of Jn peak
(proportional to the distance between the center of the pro-
tofilaments) remained constant in all cases. From these data,
the average microtubule diameters and average protofila-
ment number were calculated (Table 1).
Except for the case of Chitax-14, in which the valleys are
remarkably less pronounced, indicating a larger proportion
of open microtubular sheets (8), the width of the peaks
and the ratio between the maximum of the J01 peak and
the minimum between J01 and J02 is very similar for all
the compounds studied. This indicates that the distribution
of protofilament numbers and the proportion of open micro-
tubular sheets should be similar for all ligand-induced
microtubules and also similar to those previously described
by electron microscopy (1,8,13,14).Effect of the modification of the ligand size,
at selected positions, in the microtubule structure
The effects of single point changes of the taxane molecule
on the interprotofilament contacts can be then calculated
from the changes in the number of protofilaments
(Table 2). When the SAXS patterns of paclitaxel-inducedBiophysical Journal 101(12) 2970–2980
TABLE 2 Changes in protofilament numbers due to single point modifications
Modification type Modification Compounds Change in pf number Average change* DV-SES (A˚3)








C7 -OH to propionyl 17/1 þ1.4 þ1.4 þ52
-OH to Fluorescein P/Flutax-1 þ1.6 þ1.6 þ366
-OH to diFluoro-Fluorescein P/Flutax-2 þ1.6 þ1.6 þ375
-OH to (CH2)6-Fluorescein P/Hexaflutax þ2.1 þ2.1 þ453
C10 -OH to Acetyl 17/C 0.8 0.75 0.2 þ48
15/P 0.3
D/21 0.9
-OH to Propionyl 17/18 1.0 1.0 þ53




PTX/DXL P/21 þ0.1 þ0.1 þ11
CPH/DXL C/21 þ0.5 þ0.25 0.3 þ8
17/D þ0.6
20/40 0.5
PTX/None P/BIII 1.7 1.7 256
*Errors, where applicable, are the standard error.
pf, protofilament; V-SES, volume of solvent-excluded surface; PTX, paclitaxel side chain; DXL, Docetaxel side chain; CPH, Cephalomannine side chain; P,
paclitaxel; D, Docetaxel; C, Cephalomannine; BIII, baccatin III.
2974 Matesanz et al.microtubules (Fig. 2 A, green line) are compared with
patterns of microtubules assembled in the presence of Chi-
tax-21 and cephalomannine (paclitaxel equivalents with
specific modifications only at the C13 side chain) (Fig. 2
A, black and red lines, respectively), the differences in the
position of the J01 maxima fell within the experimental error
(Table 2). The same result was obtained for the rest of the
taxanes with single point modifications at the C13 side chain
(Table 2). Only the removal of the C13 side chain (from
paclitaxel to baccatin III) resulted in a large decrease of
1.7 units in the average number of protofilaments.
The result indicates that the change in microtubule struc-
ture observed between paclitaxel-induced and docetaxel-
induced microtubules (13,14) was actually not due to the
modification at the side chain. However, the results point
toward a strong influence of the volume of the side chain
in the interaction with the binding site. In fact, the size of
the two side chains involved is nearly the same as shown
by the calculation of the change in V-SES by the side chain
(Table 2) (size change if phenyl is exchanged for tert-
butyl þ11 A˚3). Exchange of these two side chains for a
different one with a similar size (butylen) (size change if
phenyl is exchanged for butylen, 15 A˚3) does not result
in an appreciable change in the protofilament number,
whereas removing the side chain that results in a volume
change of256 A˚3 results in a large decrease of the average
number of protofilaments.Biophysical Journal 101(12) 2970–2980It is therefore evident that the difference observed
between the structure of the microtubules induced by pacli-
taxel and that of the microtubules induced by docetaxel
should arise from the difference of the group at position
10 (acetyl group versus a free OH moiety, for paclitaxel
and docetaxel, respectively), and corresponds to a volume
decrease of 42 A˚3
An increase in volume at position 10 resulted in a small
but consistent decrease in the number of protofilaments of
the induced microtubules. The introduction of acetyl (ceph-
alomannine; Fig. 2 B, red line) or propionyl (þ53 A˚3)
groups (Chitax-18; Fig. 2 B, black line) at position 10 re-
sulted in a decrease of the microtubule diameter compared
with Chitax-17 (Fig. 2 B, green line) (Table 2). When an
acetyl group was introduced as a single point modification
at position 10, the average decrease in the number of proto-
filaments was 0.7. When a propionyl group was introduced,
the decrease corresponded to 1.0 protofilament.
An opposite effect is seen for the other group in the north
face of the molecule, C7, which also points toward the inter-
protofilament space in both binding sites. The introduction
of bulky groups, such as fluorescein (þ366 A˚3) and difluoro-
fluorescein (þ375 A˚3) (Flutax-1 and Flutax-2), at this posi-
tion instead of the free hydroxyl resulted in a large increase
in the microtubule diameter (16). However, the relatively
large size of these groups may result in additional interac-
tions. Therefore, a further comparison experiment was also
Taxanes Modify Microtubule Structure 2975performed for analogs bearing a smaller propionyl side chain
(þ53 A˚3). Thus, the effect observed could be compared to
that monitored for the equivalent change at position 10.
The introduction of a propionyl side chain at C7 (Chitax-
17/Chitax-1) resulted in an increase in the diameter of the
microtubules (Fig. 2 C, green and black lines, respectively)
equivalent to 1.4 extra protofilaments. Accordingly, this
variation was similar to that observed for the introduction
of the fluorescein moieties mentioned above, with 1.6 extra
protofilaments (see Table 2). It is interesting that the intro-
duction of a bulkier group such as 7-hexaflutax (þ453 A˚3)
resulted in the largest change in diameter observed, corre-
sponding to 2.1 protofilaments, as also shown in Table 2.
Since the south face of the molecule and, more precisely,
the benzyl moiety at the C2 position of the taxane ring
strongly influences the interactions of these compounds
with the luminal site (23) and, very probably, also with
the pore site (20), we have studied the modifications at C2
that highly modulate the binding affinity. In both cases,
the C2-modified molecules with groups at the meta position
of the ring, which increase the binding affinity, amplified the
microtubule diameter (Table 2). An average increase of 0.7
units was observed for compounds bearing an azide substit-
uent, which added an extra 35 A˚3 (-N3, Chitax-14; Fig. 2 D,
black line) and an average increase of 0.8 units, for the
methoxy-containing analogs, which added 24 A˚3 (-OCH3,
Chitax-13; Fig. 2 D, green line).NMR and molecular modeling
Three-dimensional models of the ligands bound to the two
alternative binding sites (the luminal and pore sites) were ob-
tained to understand the effects, at the structural level, of
ligand binding to microtubules. A combined NMR and
modeling approach was employed when NMR experiments
could be performed. Unfortunately, taxane solubility prob-
lems precluded general use of the combined procedure. How-
ever, in the case of docetaxel (21,23), paclitaxel, chitax-42,
and flutax-2 (this work), it was possible to obtain NMR-based
information regarding the bioactive conformations and the
binding epitopes of the ligands, and this information was em-
ployed as a guide for the modeling procedures.
STD experiments detect magnetization transfer from the
protein to a bound ligand. Only bound ligands show STD
signals and, as in any NOE-type experiment, the STD effect
observed depends on the distance between the protons of the
protein and those of the ligand, thus providing a useful tool
to detect the ligand epitope and to structurally probe the
binding site. This information is of paramount importance
to improve the docking models. However, there are kinetic
requirements for these experiments to be successful. Indeed,
STD and TR-NOESY experiments (which permit deduction
of the bioactive conformation of the ligand) require a fast
off-rate in the relaxation timescale. Therefore, as previously
discussed, the characteristic slow dissociation of ligandsfrom the luminal site in the microtubules precludes observa-
tion of the TR-NOESY and STD signals from the ligand
when it is bound to this site (23). As a matter of fact, the
calculated STD profiles of the taxanes bound to the luminal
site cannot reproduce those experimentally determined (21).
Thus, the NMR-based information for these systems can
only be employed to model the pore-bound poses.
Three model compounds were selected for the construc-
tion of the model average STD profile of taxanes. Paclitaxel
and docetaxel were selected as lead compounds in the series,
whereas Chitax-42 (a low-affinity compound with a modi-
fied linker at C2) was chosen to determine whether all active
taxanes bind to microtubules in the same way. Flutax-2 (16)
was also measured as an example of those analogs bearing
bulky probes at C7. STD and TR-NOESY data were
acquired for paclitaxel, Chitax-42, and Flutax-2 (experi-
mental data are shown in Fig. 3 A, and a higher-resolution
version of the TR-NOESY spectra is available in Fig. S1
in the Supporting Material). Docetaxel data were taken
from our previous studies (21,23). Regarding the taxane
part of the molecules, the molecular conformation deduced
from TR-NOESY spectra was found to be identical to that
previously described for docetaxel (21,23).
Flutax-2 was modeled in the pore site (Fig. 3 B) using
its experimentally measured STD profile (Fig. 3 C), as
described in Materials and Methods. The NRMSD factor
of the best model was 19.38%, in between those obtained
for the previously published models of docetaxel (9.9%)
and discodermolide (22.4%) bound to microtubules (21).
Given the bulky group at C7, which may be involved in
additional interactions with the binding site, STD effects
of Flutax-2 protons were not employed to build the model
average STD profile for the common protons of paclitaxel,
which was later used to model the nonfluorescent ligands.
Four selected ligands (cephalomannine,Chitax-1,Chitax-4,
and Chitax-17, which differ in single points at C7 (Chitax-17
and cephalomannine), C10 (Chitax-17 and Chitax-1), and C2
(Chitax-1 and Chitax-4)) were modeled in the pore site em-
ploying the model average STD profile of taxanes. These
ligands were chosen because of their possible influence on
the microtubule interprotofilament contacts described above.
As in the case of Flutax-2, the compounds were first docked
into the pore site, and they produced different poses. After
this procedure, the geometries of the docking poses were em-
ployed to calculate the expected STD profiles (30). The poses
were then classified by comparing their expected STD values
to those of the model average taxane (Fig. 3 D), and their
geometries were compared to those experimentally deter-
mined for docetaxel (23) and to those estimated for theT-Taxol
conformation (31). Based on the conservation of the TR-
NOESY profile, only those models in which the structure of
the ligand was compatible with either of these geometries
were further considered (Table S1). The NRMSD between
the STD estimations was considered to quantify the simi-
larities, as described in the Materials and Methods. TheBiophysical Journal 101(12) 2970–2980
FIGURE 3 NMR directed modeling of the
ligands bound to the pore site. (A) Off-resonance
NMR experiment (500 MHz) (lower line) and
STD spectra (upper line) of Flutax-2 bound to
microtubules (Inset) TR-NOESY spectra (mixing
time, 200 ms) of Flutax-2 in the presence of micro-
tubules (D2O, 310 K) (a large, high-resolution
version of this file is available in the Supporting
Material). (B) Best model of Flutax-2 docked
into the pore site. Protein residues considered in
CORCEMA-ST calculations are shown in stick
format. (C) Experimental STD profile of Flutax-2
bound to microtubules (black line and circles)
and calculated STD profile of the best model of
Flutax-2 docked into the pore site (red line and
squares). (D) Average STD profile of the common
protons of paclitaxel, docetaxel, and Chitax-42
(black line and circles) compared with the calcu-
lated STD profiles of cephalomannine (red line
and squares), Chitax-1 (green line and squares),
Chitax-17 (blue line and squares), and Chitax-4
(pink line and squares) docked into the pore site.
X axis values for C and D are placed over the sym-
bols and represent the common protons of the tax-
ane core and/or the fluorescein moiety of Flutax-2.
The order of the points has been selected so that
points representing protons that are close in the
graph are also close in the taxane molecule (pro-
tons not observable by STD keep its space but
are not plotted). Spacing and connectivity of the
points are arbitrary for presentation purposes.
2976 Matesanz et al.NRMSD values obtained (cephalomannine, 18.93%; Chitax-
1, 18.26%; Chitax-17, 16.23%; and Chitax-4, 18.79%) and
the models were between those determined for the best struc-
tures previously obtained for docetaxel and discodermolide
(21) (Fig. 4, A–C). The ligands were found to bind between
the tubulin b-subunit, close to the luminal site (b1, following
the Magnani nomenclature (32)), and the a-subunit of the
next dimer in the protofilament (a2; see the cyan structure in
Fig. 5 A of Canales et al. (21)), as previously described for do-
cetaxel (21).However, although the locationof thebinding site
was similar to that described byMagnani (but rather different
from that found by Freedman et al. (33), close to subunits b1
and b4), the binding pose of the ligands was rather different
from that described by Magnani (32).
Alternatively, the four ligands were modeled in the
luminal binding site (1JFF model) (17) by direct docking
of the geometries constructed from the TR-NOESY-deter-
mined docetaxel conformation (23), as previously described
(34) (Fig. 4, E–H).
The geometries of the best docking poses were considered
as initial structures for MD simulations. In this way, the influ-
ence of the different ligands on the interprotofilament contacts
was evaluated. As hypothesized, the different chemical moie-
ties at the peripheral substitutions made distinct and specific
contacts with determined protein regions. Local perturbationBiophysical Journal 101(12) 2970–2980of the conformations of the H3 and S3 elements of the
b-tubulin subunit at the right side of the pore (orange subunit)
was observed when the ligand was bound to the pore site
(Fig. 4, A–C). Alternatively, perturbations in the topology of
the b-tubulin M-loop, which contains the luminal site, were
detected when the ligand was bound to this site (Fig. 4,
E–H). These changes in the protein conformation are likely
to result in variations of the interprotofilament contacts.
Fig. S2 shows the effect of the cephalomannine, Chitax-17,
Chitax-1, and Chitax-4 series in the M-loop. They induced
12.6, 13.4, 14.8, and 15.2 protofilament-containing microtu-
bules, respectively. It could be deduced that these molecules,
especially cephalomannine and Chitax-17, induced the
closing of the M-loop toward the luminal site, thus giving
rise to the formation of microtubules with a low number of
protofilaments.DISCUSSION
To better understand the mechanism of MSA-induced
microtubule assembly and why interprotofilament contacts
and subsequently the microtubule structure are altered
compared with GTP-induced assembly, different taxanes
with groups of different sizes at selected positions were em-
ployed. We then observed how modification in the taxane
FIGURE 4 Models of ligands bound to microtu-
bules. (A–C) Ligands bound to pore site: (A) ceph-
alomannine; (B) Chitax-1; and (C) Flutax-2.
Magenta, H3 helix of the b3-tubulin subunit;
white, S3 of the b3-tubulin subunit. (D) Scheme
of the interaction of the ligand at both binding sites
with the structural elements responsible for the
interprotofilament interaction. The scheme shows
the positions of H3, S3, and the M-loop in the in-
terprotofilament interface with respect to the two
possible binding sites for the taxanes, as well as
the substituents of the ligands that interact with
them, altering the interprotofilament contacts. A
ligand bound to the pore site will interact with
H3 through the substituent at position C7, in-
creasing the interprotofilament angle, and with S3
through the substituent at position C10, decreasing
the angle. A ligand bound to the luminal site will
interact with the M-loop through the substituent
at position C10, producing the same effect as in
the pore site. The microtubule is seen from the
plus end. (E–H) Ligands bound to the luminal
site: (E) cephalomannine; (F) Chitax-1; (G) Chi-
tax-4; and (H) Chitax-17. Magenta, H3 helix of
the b3-tubulin subunit; white, S3 of the b3-tubulin
subunit; yellow, M-loop of the b1-tubulin subunit.
Model structures are available in the Supporting
Material.
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unlikely that the general features of the interaction of the
ligand with the binding sites would be altered by these
minor modifications. NMR-directed models of the formed
complexes have been constructed to understand, at high
resolution, how the different taxanes modify microtubule
structure and cause stabilization. In this way, we have con-
structed a data-directed model of the interaction of taxanes
with both the pore and luminal sites of microtubules, and of
the conformational effects that binding to these sites pro-
duces in contacting tubulin subunits. Thus, the SAXS
data, and the observed modifications in the number of pro-
tofilaments, can be discussed in terms of the NMR-directed
docking models obtained.How does ligand binding to the pore and luminal
sites affect microtubule structure?
To properly understand the effects of changes in the ligand
side chains on the interprotofilament structure, we carefully
examined models of the complexes of the ligands with bothbinding sites. Our initial working hypothesis was that the
interactions of the different taxane ligands with the pore
binding site (19,35), located between the protofilaments,
should be the one most likely involved in the modifications
observed in the interprotofilament angle and thus in
the average number of protofilaments of which the microtu-
bule cylindrical structure is composed. In agreement with
this hypothesis, the only compound known to bind exclu-
sively to the microtubule pore, 7-hexaflutax (18,20), is the
ligand that produces the largest effect on the microtubule
structure.
Given the transient nature of the interaction of all taxanes
except Hexaflutax with the pore site, it is only possible to
determine the ratio of compound bound to each of the sites
for the fluorescent compounds Flutax-1 (10% outer site)
and Flutax-2 (1% outer site) (16). However, for docetaxel,
STD and TR-NOESY NMR analysis of the ligand-receptor
systems also indicates that a significant percentage of nonflu-
orescent taxanes would have to be bound to the pore site (23).
However, the strong difference between the ratios of
binding of these three compounds—Flutax-1, Flutax-2,Biophysical Journal 101(12) 2970–2980
2978 Matesanz et al.and Hexaflutax—to both sites, as compared with the simi-
larity of sizes of the groups (366, 375, and 453 A˚3, respec-
tively) and the microtubules induced by these drugs (14.6,
14.6, and 15.1 protofilaments, respectively) suggests that
either the effect exerted is through both luminal and pore
sites or that only a small proportion of the ligand is enough
to produce the effect on microtubule structure. Thus, to gain
information about the specific effect, models of the interac-
tion with both the pore and luminal sites have to be
analyzed.
The results indicate that the main effect of ligands at both
the pore site and the luminal site is due to modification of the
size of groups at positions C7 andC10. The analysis of the 3D
models of the ligands derived from NMR and docking simu-
lations with O-substituents at the north face of the molecule
(taxane positions C7 andC10) reveals awell-definedmode of
interaction with the pore site. The groups at these positions
strongly interact with the secondary H3 and S3 structure
elements of the b-tubulin subunit at the adjacent protofila-
ment, modifying their molecular conformations (Fig. 4 D
and Fig. S2 A), whereas the positions that are relevant to
the binding, C2 and C13, are oriented toward the center of
the protofilament (Fig. 4). When no substituents are present
at the hydroxyl groups at C7 and C10, the groups are exposed
to the solvent, making favorable interactions with the water
molecules, and in turn do not interact with the protein
(accordingly, compounds with no substituents at the hy-
droxyl groups at C7 and C10, such as docetaxel, Chitax-15,
and Chitax-17, have little influence on themicrotubule diam-
eter). It is fitting that when a hydrophobic group is present at
this location, the protein rearranges its conformation to
protect the nonpolar areas from the solvent. When the substi-
tution takes place at C7, which is close to the surface of the
pore, the H3 helix changes its topology, resulting in a confor-
mation that is more compact the bigger the side chain is. This
in turn results in protofilament-protofilament interactions
with larger interprotofilament angles. Alternatively, for the
C10-substituted analogs, the modified position is closer to
the inner surface. In this case, the tubulin S3 strand rearranges
to close the interprotofilament contacts in the inner part of the
protein. This process involves a reduction in the interprotofi-
lament angle, and thus, thinner microtubules, with fewer pro-
tofilaments, are formed. The effect on the pore structure can
be clearly seen in Fig. 4. In the presence of cephalomannine
(Fig. 4 A), which contains an acetyl group at position 10 and
a hydroxyl at position 7, the H3 helix is not well structured
(magenta) and is located far from the ligand. In contrast,
when the C10 acetyl is removed and a propionyl group is
introduced at C7 (Chitax-1 (Fig. 4 B)), the helix becomes
stable and interacts with the ligand. A similar effect can be
observed with Flutax-2 (Fig. 4 C).
The modeling indicates that when the ligands are bound
to the luminal site, their influence is exerted through
changes in the orientation of the tubulin M-loop (see
Fig. 4, D–G, and Fig. S2 B). A similar effect was observedBiophysical Journal 101(12) 2970–2980by Mitra and Sept (36) in a large-scale molecular simulation
employing the T-taxol conformation (37). This indicates
that, as previously proposed, the effect on this loop is one
of the reasons for the microtubule stabilizing effect. Substi-
tutions at taxane positions C7 and C10 produce different
orientations of this secondary tubulin structure element.
Different structures of the M-loop are observed when an
acyl substituent is at position 10 (Fig. S2 B), as with ceph-
alomannine (yellow loop), or when a large substituent is
located at position 7, as with Chitax-1 (green loop). It is
interesting that for nonsubstituted hydroxyl groups at C7
and C10 (as in Chitax-17), the M-loop adopts the interme-
diate orientation (Fig. S2 B, white loop) between those
described above. Looking at the structural basis for the
observed variations, the presence of the acyl substituent at
position 10 induces changes in the orientation of the
M-loop, which shifts inward due to contacts between the
acyl moiety and Arg278 and Thr276. These interactions result
in the existence of closer contacts between protofilaments in
the luminal part of the microtubule wall and therefore in
smaller interprotofilament angles. Microtubules assembled
in the presence of Chitax-17 resulted in a microtubule
cylinder with an average of 13.4 protofilaments, whereas
cephalomannine microtubules only contained 12.6 protofi-
laments. In contrast, the presence of substituents at taxane
position 7 induced the outward shifting of the M-loop due
to contacts between the acyl group and Gln282. This alterna-
tive shift results in the assembly of microtubules with larger
interprotofilament angles. In fact, Chitax-17 microtubules
have 13.4 protofilaments, whereas Chitax-1 microtubules
have 14.8.
The models of the ligands docked into both the pore and
luminal binding sites (Fig. 4) indicate that the C13 side
chain is not interacting with the loops responsible for the in-
terprotofilament contacts. Thus, the large change observed
in its absence should be the result of a different pose of bac-
catin III in the sites, farther away from the S3 and H3 loops
in the pore site and from the M-loop in the luminal site.
The increase in volume of the meta group of the benzyl
moiety at taxane position C2 produced alternative variations
at other locations in the luminal binding pocket. As a key
example, incorporation of an azide moiety at the C2 aro-
matic ring resulted in a closer interaction of the ligand
with His229, which has been proposed as the main reason
for the observed increase in affinity (23). This intermolec-
ular interaction slightly modified the presentation of the
ligand and forced a large movement of the M-loop toward
the interprotofilament space (Fig. S2 B, blue loop). This
motion produced the concomitant change in the number of
protofilaments, which increases from 14.8 for Chitax-1 to
15.2 for Chitax-4. This effect can also be easily observed
by inspecting Fig. 4. In the presence of just a hydroxyl group
(as for Chitax-17 (Fig. 4 H)), the M-loop packs closer to the
ligand than it does in the presence of an acetyl group at posi-
tion 7 (as for Chitax-1, Fig. 4 F). This effect is reinforced
Taxanes Modify Microtubule Structure 2979with the addition of the N3 moiety to the aromatic ring at C2
(as for Chitax-4, fig. 4G).CONCLUSIONS
The mechanisms of ligand-induced microtubule stabiliza-
tion have been explored with a set of taxane analogs. These
ligands modify the structure of these polymers by altering
the interprotofilament contacts as detected by SAXS.
Modeling protocols, assisted by NMR experiments, were
used for different protein complexes containing ligands
bound at the pore site or at the luminal site. The modeled
3D structures were employed to analyze the microtubule
structural changes detected, providing plausible explana-
tions for the structural influence of these compounds in
modulating microtubule assembly.
Although it is not strictly possible to isolate the individual
effects arising from ligand binding to the luminal or pore
site, simulations indicate that the binding process strongly
influences the interactions at three tubulin regions, with
different well-defined secondary-structure elements. These
regions, the S7-H9 loop (M-loop), helix H3, and the S3
strand (Fig. 4 D) have been described as key elements for
interprotofilament interactions (17) and could be selectively
targeted by employing the adequately designed analogs.SUPPORTING MATERIAL
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